34% of CNS drugs side effects are caused by gene – drug interactions and not by drug – drug interactions.
CONTACT
Evrota 25-27, Kifisia 145 64
+30 2111021821
info@idnagenomics.com
ΓΕΜΗ 152515201000
We are here to support you
for your patients’ benefit
Precision Medicine is the emerging field of Medicine for the prevention, diagnosis and treatment of diseases based on the inter-individual differences that are driven by genes, the environment and lifestyle.
This approach allows physicians and researchers to accurately predict which treatment is appropriate for each patient on an individual basis.
Pharmacogenetics (PGx) studies and analyses patients' response to drugs, through correlating their gene expression or genetic polymorphisms (SNPs) with drug efficacy or toxicity.
PGx analysis benefits
Optimal treatment choice and reduced possibility of treatment failure
-Patients do not respond to medication the same way, therefore drugs do not have the same degree of effectiveness
-‘Trial and error’ approach is avoided
Fewer side effects
- Serious drug side effects (e.g., chronic liver or kidney damage) can be prevented by identifying genetic polymorphisms
Treatment cost reduction
-Reducing the side effects of failed drug trials, response times and polypharmacy to treat a condition, leads to a substantial cost reduction in healthcare
Better quality of life for patients
- Initiating treatment using medication with an improved efficacy and safety profile
- Better treatment compliance
- Reduced absence from work
Higher efficiency
PGx analysis significantly improved the therapeutic effect in psychiatric patients with depressive disorder (antipsychotics & antidepressants).
PGx analysis led to an increase in both the clinical response and remission in patients with major depression.
Fewer side effects
PGx analysis helps the physician to offer their patients
- the most effective treatment
- at the appropriate dose
- with the fewer possible side effects due to drug co-administration
Total treatment cost reduction
PGx analysis reduced the cost of care and treatment in patients with schizophrenia by 70%.
PGx analysis refers to patients
- With chronic diseases and polypharmacy
- After initial diagnosis
- Not responding to treatment
- Non – compliant to treatment
Simple and fast process
Order
Contact your physician to get your test
Collect sample
Use the sterile cotton swabs provided for the saliva sample
Sample dispatch
Send the saliva sample & the filled-in forms to iDNA Genomics
Results
We will send your personalised report, within 15 business days after having received your sample
iDNA PGx CNS Test
iDNA PGx CNS Test offers Pharmacogenomic analysis of drugs related to Central Nervous System (CNS) diseases. This test can help the physician choose the appropriate individualised treatment for their patient: a drug and a specific dose at which the patient will have the best response with the minimum side effects.
The iDNA PGx CNS Test is CE marked and certified as an in vitro Diagnostics (IVD) medical device.